DalsnaFinance

Lundbeck to present new patient data on neuroendocrine and neuroimmunology programs at ENDO 2026

Markets PR Newswire By PR Newswire 10 Jun 2026 06:22 1 min read
Lundbeck to present new patient data on neuroendocrine and neuroimmunology programs at ENDO 2026

Upcoming presentations at ENDO 2026 highlight Lundbeck's Focused Innovator strategy and continued expansion into rare neuroendocrine diseases with high unmet medical needs The scientific program showcases Lundbeck's investigational neurohormonal and neuroimmunological targeted therapeutic...

Upcoming presentations at ENDO 2026 highlight Lundbeck's Focused Innovator strategy and continued expansion into rare neuroendocrine diseases with high unmet medical needs The scientific program showcases Lundbeck's investigational neurohormonal and neuroimmunological targeted therapeutic...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.